obesity drug news today glp-1 september 29 2025 US health agency unveils weight-loss coverage model Lilly hikes revenue forecasts on

Serum FAM19A5 levels: A novel biomarker for neuroinflammation and neurodegeneration in major depressive disorder

J Am Chem Soc 123:839850

Companies who get this right have an opportunity to realize the benefits of what may become the largest market the biopharmaceutical industry has ever seen, with analysts projecting class sales to be in the $70-100 billion range by 2030

doi: 10.1080/03007995.2022.2124071 265 RapoportEABaigMPuliSR

Monitoring requirements during the initial period include regular blood glucose checks if you have diabetes, particularly if you take insulin or sulfonylureas, as doses may need adjustment to prevent hypoglycaemia

Diagnosis and treatment of interstitial cystitis/bladder pain syndrome